Adial Pharmaceuticals Says Exceeds Enrollment Target In ONWARD Phase 3 Trial Of AD04 For Treatment of Patients With Alcohol Use Disorder
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL, ADILW)))) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of
